Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease
<p>The objective of the study was to investigate the kinetics and metabolism of caffeine in serum from patients with Parkinson disease (PD) and controls using liquid chromatography–mass spectrometry.</p>